Articles about Biotechnology, Pharmaceutical and Healthcare

00:34 EDT 31st August 2014 | BioPortfolio

Latest Articles on life science, biotechnology, pharmaceutical and healthcare topics and current issues.

Showing News Articles 1–25 of 35,000+

Saturday 30th August 2014

Enzo Life Sciences SUMO-Qapture-T kit for isolation and enrichment of SUMOylated proteins

Enzo Life Sciences offers a comprehensive line of research tools for the complete isolation of SUMOylated proteins. SUMOylation of target proteins is involved in a range of cellular processes such as nuclear protein targeting, formation of sub-nuclear complexes, regulation of transcriptional activities and control of protein stability. The product is suitable for the capture and isolation of SUMO...

Labwit ZXRD/ZXFD programmable drying ovens

The Labwit forced-air drying ovens are engineered for daily work - from routing simple glassware-drying sterilisation applications up to 200-300°C, to complex controlled-heating applications, eg, aging, bonding, curing, heat treat annealing, stress relieving, burn-in, hardening test purposes, etc. The company provide ovens with two optional heating modes: ZXRD-series back heating and ZXFD-ser...

Statebourne Cryogenics Biorack storage system for LN2 refrigerators

Statebourne Cryogenics has developed the Biorack racking system based on a 133 x 133 mm footprint to accommodate blood bags, cord blood bags, Falcon tubes, 96-well plates and IVF straws in a narrow-neck LN2 refrigerator. The Biorack range of LN2 freezers holds up to 6000 x 2 mL cryovials in 100-place cryoboxes. The refrigerators have a neck diameter of 216 mm and a low loss rate (<1 L per day)...

HTL Discovery Pro pipettes

HTL has launched the Discovery Pro pipette - a product with low mass and light piston actions. The body of the pipette is carefully engineered to comfortably accommodate those with large or small hand shapes and sizes. The product’s contoured shape eases the required grip strength, and is said to make pipetting motions effortless. The tip ejection force is said to have been reduced by more...

Friday 29th August 2014

[News] Lenalidomide in combination with R-CHOP in lymphoma

Lenalidomide combined with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) shows activity in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), new research suggests.

[News] Rituximab for low-grade follicular lymphoma?

Retreatment with rituximab on an as-needed basis provides comparable disease control with a lower total rituximab dose compared with maintenance rituximab for low grade follicular lymphoma, according to a new study.

[Correspondence] Is respiratory protection appropriate in the Ebola response?

We write to express our concern about one aspect of the response to the current epidemic of Ebola that has, so far, received little attention, lacks an evidence base, and might be counterproductive.

[In Context] Making colour in the mind

People visiting The National Gallery (London, UK) expect to look at its paintings, but few visitors think about the chemistry of the coloured pigments used by the artists or the neuroscience and neurophysiology of their own sight. The curators of the...

Hospitals must promote healthy food to their staff, says government

Hospital trusts must provide healthy eating options for their staff as well as patients, under new rules on food quality in NHS organisations.

Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation The COPPS-2 Randomized Clinical Trial

ImportancePostpericardiotomy syndrome, postoperative atrial fibrillation (AF), and postoperative effusions may be responsible for increased morbidity and health care costs after cardiac surgery. Postoperative use of colchicine prevented these complic...

Proteintech antibodies for ciliogenesis

The primary cilium acts as a sensory organelle that transfers information from the environment to the cell interior. This organelle is crucial for regulating important cellular processes, including the cell cycle, cytoskeletal organisation, intraflagellar transport and signalling pathways such as hedgehog, notch and canonical and non-canonical Wnt/planar call polarity (PCP) pathways. Proteintech h...

Aves Labs Neuronal Cell Markers

Aves Labs chicken-produced neural cell marker antibodies can be used along with existing mouse or rabbit antibodies in double-labelling studies. The neuronal cell markers are made against sequences that are 100% shared between mouse and human proteins, ensuring that the neural cell marker antibodies will react with a wide range of different mammalian species in addition to mice and humans. In som...

Judge Rules Against Strict Texas Abortion Law

 News outlets quickly reported the impact of the judge's decision. USA Today: U.S. Judge Voids Key Piece Of Texas Abortion Law A federal judge Friday struck down a major provision of Texas's strict abortion law that would have forced all but a handful of clinics to close next week. The law, passed last year by the Republican legislature, required abortion facilities to meet state standards fo...

Consumers Will Owe Uncle Sam If They Got Health Insurance Subsidies Mistakenly

Consumers getting government subsidies for health insurance who are later found ineligible for those payments will owe the government, but not necessarily the full amount, according to the Treasury Department. The clarified rule could affect some of the 300,000 people facing a Sept. 5 deadline to submit additional documents to confirm their citizenship or immigration status, and also apply bro...

Drug-Delivery Vehicle Could Limit Spread of HIV, AIDS

A unique method for delivering compounds that could positively impact the global battle against HIV and AIDS may be possible, thanks to researchers in Penn State's College of Agricultural Sciences. A semi-soft vaginal suppository made from the seaweed-derived food ingredient carrageenan an

Isis Initiates Phase 3 Study of FCS Drug

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.Read more about Isis Initiates Phase 3 Study of FCS DrugCo

Amgen Submits BLA for Cholesterol-Lowering Pill

Amgen has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for evolocumab seeking approval for the treatment of high cholesterol.Read more about Amgen Su

FDA Fast Tracks Pfizer's C.diff Vaccine

Pfizer Inc. has announced  that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company’s investigationalClostridium difficile (C. difficile) vaccine candidate (PF-06425090). Currently in Phase 2 clinical development, the vaccine candidate is designed to prevent C.

Infographic: FSA Employer Trends

To rollover or not to rollover your unused FSA contributions? Since the Treasury modified the “Use-or-Lose” rule in late 2013, employers and employees alike are questioning whether to enact the new carry-over option stick with the traditional grace period. FSA Rollover or Grace Period? Because the new carry-over option didn’t go into effect until this […]The post Infographic: FSA Emplo...

Human medicines European public assessment report (EPAR): Prolia, denosumab, Revision: 6, Authorised

Human medicines European public assessment report (EPAR): Capecitabine Teva, capecitabine, Revision: 3, Authorised

Princess Margaret Cancer Centre launches myeloproliferative neoplasm program

Thanks to a generous gift of $2.4 million from Elizabeth and Tony Comper, the Princess Margaret Cancer Centre will establish Canada’s first Myeloproliferative Neoplasm Program (MPN). Myeloproliferative neoplasms (MPNs) are stem cell disorders affecting blood and bone marrow in which there is uncontrolled production of blood cells. Patients with MPNs can transform to an aggressive [&hell...

Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Revision: 12, Authorised

Human medicines European public assessment report (EPAR): Capecitabine SUN, capecitabine, Revision: 1, Authorised

Medicure’s Tardoxal shows positive results in Phase 2 trial

Specialty pharmaceutical company Medicure Inc. has divulged the results of its Phase 2 clinical trial for Tardoxal, a drug for the treatment of Tardive Dyskenesia (TEND-TD). After twelve weeks of treatment in an interim analysis of 37 patients, results showed greater improvement in AIMS (Abnormal Involuntary Movement Scale) from baseline versus placebo. With only minute [&hellip

Search BioPortfolio: